Automated liquid chromatography-tandem mass spectrometry method for the analysis of firocoxib in urine and plasma from horse and dog

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 853, Issue 1-2, 2007, Pages 333-345

  Letendre, Laura ^a   Kvaternick, Valerie ^a   Tecle, Berhane ^a   Fischer, James ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Automation; Dog; Firocoxib; Horse; LC MS MS; NSAID; Plasma; Urine

Indexed keywords

DOG; FIROCOXIB; HORSE;

BLOOD; EXTRACTION; IONIZATION; MAMMALS; MASS SPECTROMETRY;

BIOMEDICAL ENGINEERING;

ACEPROMAZINE MALEATE; AMMONIUM FORMATE; CARPROFEN; FIROCOXIB; IVERMECTIN; KETAMINE; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; PRAZIQUANTEL; ROFECOXIB; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; AUTOMATION; DOG; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STRUCTURE; DRUG URINE LEVEL; EVALUATION; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE; IONIZATION; LIQUID CHROMATOGRAPHY; NONHUMAN; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSED PHASE LIQUID CHROMATOGRAPHY; SENSITIVITY ANALYSIS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; URINALYSIS; VALIDATION PROCESS;

4-BUTYROLACTONE; ANIMALS; CHROMATOGRAPHY, LIQUID; DOGS; HORSES; MOLECULAR STRUCTURE; REPRODUCIBILITY OF RESULTS; SULFONES; TANDEM MASS SPECTROMETRY;

CANIS FAMILIARIS; EQUIDAE;

EID: 34250183083     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2007.03.049     Document Type: Article

References (23)

1. McCann M.E., Rickes E.L., Hora D.F., Cunningham P.K., Zhang D., Brideau C., Cameron Black W., and Hickey G.J. Am. J. Vet. Res. 66 (2005) 1278
2. McCann M.E., Andersen D.R., Zhang D., Brideau C., Cameron Black W., Hanson P.D., and Hickey G.J. Am. J. Vet. Res. 65 (2004) 503
3. Langenbach R., Morham S.G., Tiano H.F., Loftin C.D., Ghanayem B.I., Chulada P.C., Mahler J.F., Lee C.A., Goulding E.H., Kluckman K.D., Kim H.S., and Smithies O. Cell 83 (1995) 483
4. Peskar B.M., Maricic N., Gretzera B., Schuligoi R., and Schmassmann A. Life Sci. 69 (2001) 2993
5. Toutain P.-L., Reymond N., Laroute V., Garcia P., Popot M.-A., Bonnaire Y., Hirsch A., and Narbe R. Am. J. Vet. Res. 65 (2004) 1542
6. Short C.R., Sams R.A., Soma L.R., and Tobin T. J. Vet. Pharmacol. Ther. 21 (1998) 144
7. Dumasia M.C., Ginn A., Hyde W., Peterson J., and Houghton E. J. Chromatogr. B 788 (2003) 297
8. Mazenko R.S., Sharbek A., Woolf E.J., Simpson R.C., and Matuszewski B.K. J. Liq. Chromatogr. Rel. Technol. 24 (2001) 2601
9. Sane R.T., Menon S., Deshpande A.Y., and Jain A. Chromatographia 61 (2005) 137
10. Stormer E., Bauer S., Kirchheiner J., Brockmoeller J., and Roots I. J. Chromatogr. B.: Anal. Technol. Biomed. Life Sci. 783 (2003) 207
11. Vallano P.T., Mazenko R.S., Woolf E.J., and Matuszewski B.K. J. Chromatogr. B 779 (2002) 249
12. Woolf E., Fu I., and Matuszewski B. J. Chromatogr. B: Biomed. Sci. Appl. 730 (1999) 221
13. Chavez-Eng C.M., Constanzer M.L., and Matuszewski B.K. J. Chromatogr. B 748 (2000) 31
14. Chavez-Eng C.M., Constanzer M.L., and Matuszewski B.K. J. Chromatogr. B 767 (2002) 117
15. Vintiloiu A., Mullett W.M., Papp R., Lubda D., and Kwong E. J. Chromatogr. A 1082 (2005) 150
16. Zhang J.Y., Fast D.M., and Breau A.P. J. Chromatogr. B 785 (2003) 123
17. Werner U., Werner D., Pahl A., Mundkowski R., Gillich M., and Brune K. Biomed. Chromatogr. 16 (2002) 56
18. Wiesner J.L., de Jager A.D., Sutherland F.C.W., Hundt H.K.L., Swart K.J., Hundt A.F., and Els J. J. Chromatogr. B 785 (2003) 115
19. Zhang J.Y., Fast D.M., and Breau A.P. J. Pharm. Bio. Med. Anal. 33 (2003) 61
20. Nageswara Rao R., Meena S., and Raghuram Rao A. J. Pharm. Bio. Med. Anal. 39 (2005) 349
21. V. Kvternick, T. Malinski, J. Wortmann, J. Fischer, P. Hanson, J. Chromatogr. B, submitted for publication.
22. FDA, Guidance for Industry: Bioanalytical Method Validation, May 2001.
23. Kiser M.M., and Dolan J.W. LC•GC Europe 17 (2004) 138